Tolerability and discontinuation effects for sertraline versus venlafaxine-XR in depression

Basit Öğe Kaydı
dc.contributor.authorSir, A
dc.contributor.authorD'Souza, R
dc.contributor.authorde Felice, N
dc.contributor.authorUguz, S
dc.contributor.authorGeorge, T
dc.contributor.authorMcIlroy, F
dc.contributor.authorLamb, W
dc.date.accessioned2024-04-24T17:48:07Z
dc.date.available2024-04-24T17:48:07Z
dc.date.issued2004
dc.departmentDicle Üniversitesien_US
dc.description24th CINP Congress -- JUN 20-24, 2004 -- Paris, FRANCEen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipCINPen_US
dc.identifier.endpageS161en_US
dc.identifier.issn1461-1457
dc.identifier.startpageS161en_US
dc.identifier.urihttps://hdl.handle.net/11468/22895
dc.identifier.volume7en_US
dc.identifier.wosWOS:000224663001010
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoenen_US
dc.publisherCambridge Univ Pressen_US
dc.relation.ispartofInternational Journal of Neuropsychopharmacology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keyword]en_US
dc.titleTolerability and discontinuation effects for sertraline versus venlafaxine-XR in depressionen_US
dc.titleTolerability and discontinuation effects for sertraline versus venlafaxine-XR in depression
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu